For BRCA1 mutation carriers, a decrease in breast cancer risk associated with HRT was found for both women with (HR = 0.52; 95% CI 0.30–0.92) and without RRBSO (HR = 0.29; 95% CI 0.13–0.69). This evidence concerns the gene BRCA1 and breast cancer.